Search in:

Expert Opinion on Pharmacotherapy Volume 22, 2021 - Issue 3

Submit an article Journal homepage

Open access

2,935

Views

CrossRef citations to date

Altmetric

Review

Advances in cyclin-dependent kinase inhibitors for the treatment of melanoma

Maximilian JulveDepartment of Surgery & Cancer, Imperial College London, London, UKCorrespondence[email protected]
View further author information

James J. ClarkDepartment of Surgery & Cancer, Imperial College London, London, UKView further author information

Mark P. LythgoeDepartment of Surgery & Cancer, Imperial College London, London, UKView further author information

Pages 351-361 | Received 22 Jun 2020, Accepted 21 Sep 2020, Published online: 08 Oct 2020

Cite this article
https://doi.org/10.1080/14656566.2020.1828348
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (9)

Laxmikant Gautam, Monika Vishwakarma, Indu Lata Kanwar, Priya Shrivastava & Suresh P. Vyas. 2023. Synbiotics for the Management of Cancer. Synbiotics for the Management of Cancer 1 40 .

Sonal M Manohar. (2022) Cyclin-dependent kinases as potential targets for colorectal cancer: past, present and future. Future Medicinal Chemistry 14:14, pages 1087-1105.
Crossref

James M. Murphy, Kyuho Jeong, Eun-Young Erin Ahn & Ssang-Taek Steve Lim. (2022) Nuclear focal adhesion kinase induces APC/C activator protein CDH1-mediated cyclin-dependent kinase 4/6 degradation and inhibits melanoma proliferation. Journal of Biological Chemistry 298:6, pages 102013.
Crossref

Hanzhi Liang, Yue Zhu, Zhiyuan Zhao, Jintong Du, Xinying Yang, Hao Fang & Xuben Hou. (2022) Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Cancer. Frontiers in Pharmacology 13.
Crossref

E. Panagiotou, G. Gomatou, I. P. Trontzas, N. Syrigos & E. Kotteas. (2021) Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials. Clinical and Translational Oncology 24:2, pages 161-192.
Crossref

Francesca Comito, Rachele Pagani, Giada Grilli, Francesca Sperandi, Andrea Ardizzoni & Barbara Melotti. (2022) Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma. Cancers 14:2, pages 271.
Crossref

Qiu Li, Lin Chen, Yu-Feng Ma, Xie-Er Jian, Jia-Hao Ji, Wen-Wei You & Pei-Liang Zhao. (2021) Development of pteridin-7(8H)-one analogues as highly potent cyclin-dependent kinase 4/6 inhibitors: Synthesis, structure-activity relationship, and biological activity. Bioorganic Chemistry 116, pages 105324.
Crossref

Konstantina Karamanou, Marco Franchi, Isabelle Proult, Romain Rivet, Demitrios Vynios & Stéphane Brézillon. (2021) Lumican Inhibits In Vivo Melanoma Metastasis by Altering Matrix-Effectors and Invadopodia Markers. Cells 10:4, pages 841.
Crossref

Margaret Ottaviano, Emilio Giunta, Marianna Tortora, Marcello Curvietto, Laura Attademo, Davide Bosso, Cinzia Cardalesi, Mario Rosanova, Pietro De Placido, Erica Pietroluongo, Vittorio Riccio, Brigitta Mucci, Sara Parola, Maria Vitale, Giovannella Palmieri, Bruno Daniele & Ester Simeone. (2021) BRAF Gene and Melanoma: Back to the Future. International Journal of Molecular Sciences 22:7, pages 3474.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Advances in cyclin-dependent kinase inhibitors for the treatment of melanoma

Articles from other publishers (9)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Advances in cyclin-dependent kinase inhibitors for the treatment of melanoma

Citations (9)

Articles from other publishers (9)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date